Akero Therapeutics Inc (AKRO)

20.40 +0.22  +1.11% NASDAQ Dec 2, 16:00 20.40 0.00  0.00% After-Hours: 19:37 USD

Akero Therapeutics EPS Estimates for Current Fiscal Year

View 4,000+ financial data types
Browse...

Historical EPS Estimates for Current Fiscal Year Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Nov. 15, 2021 Upgrade
Nov. 14, 2021 Upgrade
Nov. 12, 2021 Upgrade
Oct. 19, 2021 Upgrade
Sept. 16, 2021 Upgrade
Sept. 10, 2021 Upgrade
Aug. 18, 2021 Upgrade
Aug. 16, 2021 Upgrade
Aug. 14, 2021 Upgrade
Aug. 13, 2021 Upgrade
July 30, 2021 Upgrade
May 17, 2021 Upgrade
May 14, 2021 Upgrade
May 13, 2021 Upgrade
March 23, 2021 Upgrade
March 22, 2021 Upgrade
March 17, 2021 Upgrade
March 16, 2021 Upgrade
March 15, 2021 Upgrade
Feb. 26, 2021 Upgrade
Feb. 25, 2021 Upgrade
Dec. 31, 2020 Upgrade
Dec. 16, 2020 Upgrade
Nov. 16, 2020 Upgrade
Nov. 13, 2020 Upgrade
   
Sept. 15, 2020 Upgrade
Sept. 10, 2020 Upgrade
Aug. 13, 2020 Upgrade
July 20, 2020 Upgrade
July 7, 2020 Upgrade
July 1, 2020 Upgrade
June 23, 2020 Upgrade
May 14, 2020 Upgrade
March 31, 2020 Upgrade
March 25, 2020 Upgrade
March 18, 2020 Upgrade
March 17, 2020 Upgrade
March 16, 2020 Upgrade
March 2, 2020 Upgrade
Dec. 31, 2019 Upgrade
Nov. 18, 2019 Upgrade
Nov. 14, 2019 Upgrade
Nov. 13, 2019 Upgrade
Nov. 12, 2019 Upgrade
Aug. 20, 2019 Upgrade
Aug. 14, 2019 Upgrade
Aug. 13, 2019 Upgrade
Aug. 12, 2019 Upgrade
July 15, 2019 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

View EPS Estimates for Current Fiscal Year for AKRO

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

Advertisement

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's. For more detailed information on specific periods, view the following:

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

Minimum Upgrade Mar 16 2021
Maximum Upgrade Jul 15 2019
Average Upgrade

News

Insider Sell: Akero Therapeutics
MT Newswires 11/05 16:58 ET
Insider Sell: Akero Therapeutics
MT Newswires 11/03 17:56 ET
MIME, LBTYA and PTEN among after hour movers
SA Breaking News 10/19 17:43 ET
Insider Sell: Akero Therapeutics
MT Newswires 10/18 17:05 ET
Insider Sell: Akero Therapeutics
MT Newswires 10/05 16:42 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.